Healthcare


W8MD Diet | COVID-19 portal | Vitamin D | Vaccine | Keto

WikiMD is the world's largest medical encyclopedia with
13,350 pages, 4,211,060 edits & 43,947,365 views.

Free unbiased diet, health and wellness info!

Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase is designated as an orphan drug by the US FDA on 3/3/2011, used in treatment of myeloproliferative disorders (polycythemia vera, essential throbocythemia, and myelofibrosis), manufactured / distributed by [[Eli Lilly and Company


edit 

WikiMD needs you!

This WikiMD article Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase is a stub. If you are familiar with the topic Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase, you can help us. Paid editors welcome!

 

Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase is part of WikiMD's free ^articles!

^Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available